ClinConnect ClinConnect Logo
Search / Trial NCT05697601

Predictors of Ovarian Cancer and Endometrial Cancer for Artificial-Intelligence-Based Screening Tools

Launched by HASANUDDIN UNIVERSITY · Jan 14, 2023

Trial Information

Current as of July 22, 2025

Recruiting

Keywords

Ovarian Cancer Endometrial Cancer Endometrial Hyperplasia Artificial Intelligence Point Of Care Testing Staging Gynecological Screening Pathology

ClinConnect Summary

This clinical trial is focused on understanding ovarian and endometrial cancers, which are types of cancers affecting women’s reproductive organs. Researchers aim to identify factors that might help predict the risk of developing these cancers in women in Indonesia. They are developing special screening tools powered by artificial intelligence to improve early detection and diagnosis of these conditions. The study will collect information from women who have been diagnosed with these cancers to find patterns that could help with future screenings.

To be eligible for this study, women must experience certain gynecological symptoms, such as irregular or heavy menstruation, pelvic pain, unusual vaginal discharge, sudden weight loss, or pain during sexual intercourse. They should also have had a routine gynecological examination. Participants in the study can expect to provide valuable information that could lead to better screening methods for ovarian and endometrial cancers, potentially improving outcomes for many women in the future. The study is currently recruiting participants, and it’s an important opportunity for those who meet the criteria to contribute to cancer research.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Women with gynaecological symptoms but not limited to
  • 1. Irregular menstruation
  • 2. Heavy bleeding during menstruation
  • 3. pelvic pain
  • 4. vaginal discharge
  • 5. sudden weight loss
  • 6. pain during sexual intercourse
  • Women who underwent routine gynaecological examination
  • Exclusion Criteria:
  • unable to undergo serial gynaecological follow-up

About Hasanuddin University

Hasanuddin University is a prestigious academic institution based in Indonesia, dedicated to advancing healthcare research and education. As a clinical trial sponsor, the university leverages its extensive expertise in medical and health sciences to conduct innovative research aimed at improving patient outcomes and addressing public health challenges. With a commitment to ethical research practices and collaboration with local and international partners, Hasanuddin University plays a vital role in contributing to the body of knowledge in clinical sciences, fostering advancements in treatment methodologies, and enhancing healthcare delivery in the region.

Locations

Makassar, South Sulawesi, Indonesia

Makassar, South Sulawesi, Indonesia

Patients applied

0 patients applied

Trial Officials

Rina Masadah, Ph.D

Study Chair

Hasanuddin University

Bumi Herman, Ph.D

Principal Investigator

Chulalongkorn University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials